Predicting the efficacy of short oligonucleotides in antisense and RNAi experiments with boosted genetic programming.
BACKGROUND
Both small interfering RNAs (siRNAs) and antisense oligonucleotides can selectively block gene expression. Although the two methods rely on different cellular mechanisms, these methods share the common property that not all oligonucleotides (oligos) are equally effective. That is, if mRNA target sites are picked at random, many of the antisense or siRNA oligos will not be effective. Algorithms that can reliably predict the efficacy of candidate oligos can greatly reduce the cost of knockdown experiments, but previous attempts to predict the efficacy of antisense oligos have had limited success. Machine learning has not previously been used to predict siRNA efficacy.


RESULTS
We develop a genetic programming based prediction system that shows promising results on both antisense and siRNA efficacy prediction. We train and evaluate our system on a previously published database of antisense efficacies and our own database of siRNA efficacies collected from the literature. The best models gave an overall correlation between predicted and observed efficacy of 0.46 on both antisense and siRNA data. As a comparison, the best correlations of support vector machine classifiers trained on the same data were 0.40 and 0.30, respectively.
Saetrom
Pål
P
Interagon AS, Medisinsk teknisk senter, N-7489 Trondheim, Norway.
D000465:Algorithms; D001185:Artificial Intelligence; D020868:Gene Silencing; D018390:Gene Targeting / Q000379:methods; D008957:Models, Genetic; D016376:Oligonucleotides, Antisense / Q000235:genetics*; D034622:RNA Interference; D034741:RNA, Small Interfering / Q000235:genetics*; D013873:Thionucleotides / Q000235:genetics
D016376:Oligonucleotides, Antisense; D034741:RNA, Small Interfering; D013873:Thionucleotides